Ger T Rijkers (Ger Rijkers)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Coronavirus Disease

Lipopolysaccharide Induced

Top Venues

Pneumonia (Nathan Qld.)

Cellular & molecular immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Merit Bartels, Eric Sala Solé, Lotte M Sauerschnig, Ger T Rijkers
Back to the Future: Immune Protection or Enhancement of Future Coronaviruses. Microorganisms 12 (3) (2024)
Merit Bartels, Eric Sala Solé, Lotte M Sauerschnig, Ger T Rijkers
Back to the Future: Immune Protection or Enhancement of Future Coronaviruses. Microorganisms 12 (3) (2024)
Merit Bartels, Eric Sala Solé, Lotte M Sauerschnig, Ger T Rijkers
Back to the Future: Immune Protection or Enhancement of Future Coronaviruses. Microorganisms 12 (3) (2024)
Jasmijn Verhoef, Ediz Klont, Frans J van Overveld, Ger T Rijkers
The long and winding road of fecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy. Expert review of anticancer therapy (2023)
Jasmijn Stroo, Michaëla Lepolder, Jean-Luc Murk, Ger T Rijkers
The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World. Vaccines 11 (9) (2023)
Bekir Karakaya, Coline H M van Moorsel, Marcel Veltkamp, Claudia Roodenburg-Benschop, Karin M Kazemier, Annette H M van der Helm-van Mil, Tom W J Huizinga, Jan C Grutters, Ger T Rijkers
A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren's Syndrome and Alters Receptor Expression as well as Functional Response. Cells 10 (8) (2021)
Esther Wittermans, Stefan M T Vestjens, Simone M C Spoorenberg, Willem L Blok, Jan C Grutters, Rob Janssen, Ger T Rijkers, Frank W J M Smeenk, G Paul Voorn, Ewoudt M W van de Garde, Willem Jan W Bos, null null, null null
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial. The European respiratory journal 58 (2) (2021)
Samantha Scharringa, Thijs W Hoffman, Diana A van Kessel, Ger T Rijkers
Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert review of clinical pharmacology 14 (11) (2021)
Ger T Rijkers, Nynke Weterings, Andres Obregon-Henao, Michaëla Lepolder, Taru S Dutt, Frans J van Overveld, Marcela Henao-Tamayo
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines 9 (8) (2021)
Ger T Rijkers, Trees Vervenne, Pieter van der Pol
More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells. Cellular & molecular immunology 17 (7) (2020)
Anat Eck, Nicole B M M Rutten, Maartje M J Singendonk, Ger T Rijkers, Paul H M Savelkoul, Clemens B Meijssen, Clarissa E Crijns, Johanna H Oudshoorn, Andries E Budding, Arine M Vlieger
Neonatal microbiota development and the effect of early life antibiotics are determined by two distinct settler types. PloS one 15 (2) (2020)
Thuc Anh Nguyen, Sophie Croon, Ger T Rijkers
Mycobacterium tuberculosis: escape room world champion. Pneumonia (Nathan Qld.) 11 (2019)
Diana van Kessel, Thijs Hoffman, Heleen van Velzen-Blad, Bob Meek, Suzan van Mens, Jan Grutters, Ger T Rijkers
Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia. Pneumonia (Nathan Qld.) 9 (2017)
Ger T Rijkers, Maria Rodriguez Gomez
Rocking pneumonia. Pneumonia (Nathan Qld.) 9 (2017)